Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for PD 1
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
Most Relevant Literature
- PD-1 immunology in the kidneys: a growing relationship.
- Molecular Imaging of PD-1 Unveils Unknown Characteristics of PD-1 Itself by Visualizing "PD-1 Microc…
- Transmembrane domain-driven PD-1 dimers mediate T cell inhibition.
- Multifaceted roles of PD-1 in tumorigenesis: From immune checkpoint to tumor cell-intrinsic function…
- Tumor cells inhibit the activation of ILC2s through up-regulating PD-1 expression.
Most Relevant Clinical Trials
- Duration of Anti-PD-1 Therapy in Metastatic Melanoma
- Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyng…
- SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Contro on PD-1/PDL-1 Tx
- Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSC…
- Decitabine and Anti-PD-1 in R/R DLBCL
